NCT07814521

Brief Summary

The goal of this study is to evaluate the impact of motivational interviewing (MI) training for Geisinger clinicians on their patients' health outcomes. Clinicians will be randomly assigned to attend or not attend mandated MI training, which will be provided at one of several sessions offered beginning in August 2026. Randomization will be stratified by department to ensure participant balance and that participating departments maintain necessary staffing levels during the training period. The study will assess whether there is a significant increase in patients' positive health behaviors and outcomes, as reflected in an index measure of multiple outcomes that may reasonably be facilitated by MI training: vaccinations and health screenings as reflected in electronic health record care gaps. Smoking cessation and other lifestyle modifications, preventive medication adherence, and behavioral health use may also be examined as part of an overall measure of MI impact. For each clinician assigned to the study, all patients they see in the 90-day period following the (would-be) date of that clinician's training will be identified and enrolled in the study. Outcome timeframes will then be relative to each unique patient's first encounter following (would-be) training.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
180,000

participants targeted

Target at P75+ for not_applicable

Timeline
22mo left

Started Aug 2026

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress7%
Aug 2026Aug 2028

First Submitted

Initial submission to the registry

August 17, 2026

Completed
1 day until next milestone

Study Start

First participant enrolled

August 18, 2026

Completed
24 days until next milestone

First Posted

Study publicly available on registry

September 11, 2026

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2028

Last Updated

September 11, 2026

Status Verified

August 1, 2026

Enrollment Period

2 years

First QC Date

August 17, 2026

Last Update Submit

September 8, 2026

Conditions

Keywords

Behavior change interventionsEvaluationTraining effectivenessHealth services researchHealthcare provider trainingPatient-provider communicationMotivational interviewing

Outcome Measures

Primary Outcomes (1)

  • Proportion of care gaps addressed

    Proportion of open care gaps closed

    Within 180 days following initial patient encounter, as of day following (would-be) assigned MI training session

Study Arms (2)

MI training

EXPERIMENTAL

Clinician is assigned to attend an MI training session

Behavioral: MI training

Control

NO INTERVENTION

Clinician is not assigned to MI training

Interventions

MI trainingBEHAVIORAL

Clinicians will be instructed to register for one MI training session that will be conducted live and in person, with possible virtual training available for those unable to attend in person

MI training

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Employed by Geisinger throughout study period
  • Working in the Community Medical Service Line (CMSL) or 65 Forward
  • MD, DO, PA
  • \>= 18 years of age
  • Attended a CMSL or 65 Forward encounter with an enrolled clinician at least once during the study period, following the MI training

You may not qualify if:

  • N/A

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Geisinger Health System

Danville, Pennsylvania, 17822, United States

Location

Study Officials

  • Amir Goren, PhD

    Geisinger Clinic

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
Clinicians will be aware of whether or not they are receiving MI training. Patients will not be informed about whether their clinicians received MI training, but they will be able to observe clinician behaviors affected by the training.
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: The design is intent-to-treat, such that clinicians randomized to training will be included in the treatment group, regardless of whether they attended the (in-person) training session.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director, Geisinger Program Evaluation

Study Record Dates

First Submitted

August 17, 2026

First Posted

September 11, 2026

Study Start

August 18, 2026

Primary Completion (Estimated)

August 1, 2028

Study Completion (Estimated)

August 1, 2028

Last Updated

September 11, 2026

Record last verified: 2026-08

Data Sharing

IPD Sharing
Will not share

Locations